Arcadia Biosciences Inc

NASDAQ RKDA

Data sourced from

and

Download Data

Arcadia Biosciences Inc Free Cash Flow for the year ending December 31, 2023: USD -15.30 M

Arcadia Biosciences Inc Free Cash Flow is USD -15.30 M for the year ending December 31, 2023, a -8.90% change year over year. Free Cash Flow is the cash flow available to a company after deducting capital expenditures from operating cash flow, indicating its ability to generate cash for expansion, debt repayment, or dividends.

Arcadia Biosciences Inc Free Cash Flow for the year ending December 31, 2022 was USD -14.05 M, a 47.72% change year over year.
Arcadia Biosciences Inc Free Cash Flow for the year ending December 31, 2021 was USD -26.88 M, a 17.44% change year over year.
Arcadia Biosciences Inc Free Cash Flow for the year ending December 31, 2020 was USD -32.55 M, a -74.31% change year over year.
Arcadia Biosciences Inc Free Cash Flow for the year ending December 31, 2019 was USD -18.68 M, a -34.54% change year over year.

NASDAQ: RKDA

Arcadia Biosciences Inc

CEO	Ms. Pamela Haley
IPO Date	May 15, 2015
Location	United States
Headquarters	202 Cousteau Place, Davis, CA, United States, 95618
Employees	21
Sector	Consumer Defensive
Industry	Packaged foods

Description

Arcadia Biosciences, Inc. produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring. The company was incorporated in 2002 and is headquartered in Dallas, Texas.

Key trends